P16083 (NQO2_HUMAN) Homo sapiens (Human)
Ribosyldihydronicotinamide dehydrogenase [quinone] UniProtKBInterProSTRINGInteractive Modelling
231 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
68 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Reduced quinone reductase 2 in complex with chloroquine | homo-2-mer | 2×ZN; 2×FAD; 2×CLQ; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with primaquine | homo-2-mer | 2×ZN; 2×FAD; 2×1PQ; 2×GOL; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with chloroquine | homo-2-mer | 2×FAD; 2×0TX; 2×ZN; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with CK2 inhibitor DMAT | homo-2-mer | 2×ZN; 2×FAD; 2×K25; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II | homo-2-mer | 2×ZN; 2×FAD; 2×ML1; | ||||
Assess | ||||||
Crystal structure analysis of QR2 in complex with resveratrol | homo-2-mer | 2×ZN; 2×FAD; 2×STL; | ||||
Assess | ||||||
Design, Synthesis and Biological Evaluation of Potent Quinoline and Pyrroloquinoline Ammosamide Ana… | homo-2-mer | 2×ZN; 2×FAD; 2×465; 1×GOL; | ||||
Assess | ||||||
Quinone Reductase 2 in Complex with Cancer Prodrug CB1954 | homo-2-mer | 3×ZN; 2×FAD; 2×CB1; | ||||
Assess | ||||||
Design, Synthesis and Biological Evaluation of Potetent Quinoline and Pyrroloquinoline Ammosamide A… | homo-2-mer | 2×ZN; 2×FAD; 2×UXH; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×YTR; | ||||
Assess | ||||||
Casimiroin analog inhibitor of quinone reductase 2 | homo-2-mer | 2×ZN; 2×EWQ; 2×FAD; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II | homo-2-mer | 2×FAD; 2×ML2; 2×ZN; 2×CL; 2×GOL; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 3×MZX; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II | homo-2-mer | 2×FAD; 2×ML1; 2×ZN; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×ZXZ; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×HGZ; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II | homo-2-mer | 2×FAD; 2×ML1; 2×ZN; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×MZX; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 3×RZW; | ||||
Assess | ||||||
Reduced quinone reductase 2 in complex with CK2 inhibitor DMAT | homo-2-mer | 2×ZN; 2×FAD; 2×K25; | ||||
Assess | ||||||
Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory activi… | homo-2-mer | 2×ZN; 4×XM5; 2×FAD; | ||||
Assess | ||||||
Reduced quinone reductase 2 in complex with acridine orange | homo-2-mer | 3×ZN; 2×FAD; 2×AO; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with ethidium | homo-2-mer | 2×ZN; 2×FAD; 3×ET; 1×SO4; | ||||
Assess | ||||||
Reduced quinone reductase 2 in complex with ethidium | homo-2-mer | 2×ZN; 2×FAD; 3×ET; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with acridine orange | homo-2-mer | 3×ZN; 2×FAD; 2×AO; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II in complex with a 2-(4-methoxy-phenyl)-5-methoxy-indol-3-… | homo-2-mer | 2×ZN; 2×FAD; 2×3ZV; 3×SO4; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×A7B; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×M42; | ||||
Assess | ||||||
Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation | homo-2-mer | 2×ZN; 1×GOL; 2×FAD; 2×M49; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×VAP; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with CK2 inhibitor TBBz | homo-2-mer | 2×ZN; 2×FAD; 2×K17; | ||||
Assess | ||||||
Oxidized quinone reductase 2 in complex with doxorubicin | homo-2-mer | 2×ZN; 2×FAD; 2×DM2; | ||||
Assess | ||||||
Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory activi… | homo-2-mer | 2×MXX; 2×FAD; 2×ZN; | ||||
Assess | ||||||
Binding of anti-cancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structu… | homo-2-mer | 2×ZN; 2×FAD; 2×CB1; | ||||
Assess | ||||||
Crystal structure of quinone reductase 2 in complex with the indolequinone MAC627 | homo-2-mer | 2×ZN; 2×FAD; 2×O73; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×VVV; 2×FAD; | ||||
Assess | ||||||
HUMAN QUINONE REDUCTASE TYPE 2 | homo-2-mer | 2×ZN; 2×FAD; | ||||
Assess | ||||||
Quinone Reductase 2 in Complex with Dopamine | homo-2-mer | 2×ZN; 2×FAD; 2×LDP; | ||||
Assess | ||||||
Human quinone oxidoreductase 2 (NQO2) in complex with the cytostatic prodrug CB1954 | homo-2-mer | 2×ZN; 2×FAD; 2×CB1; | ||||
Assess | ||||||
Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation | homo-2-mer | 2×ZN; 2×FAD; 2×372; 1×GOL; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II | homo-2-mer | 2×FAD; 2×ML2; 2×ZN; | ||||
Assess | ||||||
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 2×ZN; 2×FAD; 2×A2Z; | ||||
Assess | ||||||
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 2×ZN; 2×FAD; 2×79X; | ||||
Assess | ||||||
HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE | homo-2-mer | 2×ZN; 2×FAD; 2×VK3; | ||||
Assess | ||||||
Quinone Reductase 2 in complex with adrenochrome | homo-2-mer | 2×ZN; 2×FAD; 2×AD1; | ||||
Assess | ||||||
The value crystal structure of apo quinone reductase 2 at 1.35A | homo-2-mer | 6×GOL; 2×ZN; | ||||
Assess | ||||||
The value 'crystal structure of fad quinone reductase 2 at 1.45A | homo-2-mer | 1×GOL; 2×FAD; 2×ZN; | ||||
Assess | ||||||
Crystal Structure of Quinone Reductase II in complex with 2-(4-aminophenyl)-5-methoxy-1-oxy-indol-3… | homo-2-mer | 2×ZN; 2×FAD; 2×3ZU; 3×SO4; | ||||
Assess | ||||||
Crystal structure of FMN quinone reductase 2 in complex with melatonin at 1.55A | homo-2-mer | 2×FMN; 2×ZN; 2×ML1; | ||||
Assess | ||||||
Crystal structure of fad quinone reductase 2 in complex with resveratrol at 1.6A | homo-2-mer | 2×FAD; 2×STL; 2×ZN; 1×GOL; | ||||
Assess | ||||||
Structure of the human quinone reductase 2 (NQO2) in complex with imiquimod | homo-2-mer | 2×ZN; 2×FAD; 4×6T0; 3×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF FMN QUINONE REDUCTASE 2 IN COMPLEX WITH RESVERATROL AT 1.85A | homo-2-mer | 2×FMN; 2×STL; 2×ZN; | ||||
Assess | ||||||
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 2×ZN; 2×FAD; 2×695; | ||||
Assess | ||||||
QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive … | homo-2-mer | 2×ZN; 2×FAD; 1×SO4; 2×V1Z; | ||||
Assess | ||||||
Crystal structure of fad quinone reductase 2 in complex with melatonin at 1.4A | homo-2-mer | 2×FAD; 2×ML1; 2×ZN; | ||||
Assess | ||||||
Structure of the human quinone reductase 2 (NQO2) in complex with crenolanib | homo-2-mer | 2×ZN; 2×FAD; 2×6T2; | ||||
Assess | ||||||
Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 6a1 | homo-2-mer | 2×ZN; 2×FAD; 2×6A1; 1×IMD; | ||||
Assess | ||||||
Crystal structure of fmn quinone reductase 2 AT 1.55A | homo-2-mer | 2×FMN; 2×ZN; | ||||
Assess | ||||||
Structure of the human quinone reductase 2 (NQO2) in complex with to CL097 | homo-2-mer | 2×ZN; 2×FAD; 5×SO4; 4×C09; | ||||
Assess | ||||||
Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 5a1 | homo-2-mer | 2×ZN; 2×FAD; 2×TE7; 1×IMD; | ||||
Assess | ||||||
Quinone Reductase 2 | homo-2-mer | 2×ZN; 2×FAD; 2×STI; 4×MRD; | ||||
Assess | ||||||
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 2×ZN; 2×FAD; 2×4X4; | ||||
Assess | ||||||
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 2×ZN; 2×FAD; 2×XRA; | ||||
Assess | ||||||
Structure of the human quinone reductase 2 (NQO2) in complex with volitinib | homo-2-mer | 2×ZN; 2×FAD; 2×V0L; | ||||
Assess | ||||||
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 2×ZN; 2×MZC; 2×FAD; | ||||
Assess | ||||||
Quinone Oxidoreductase (NQ02) bound to NSC13000 | homo-2-mer | 2×ZN; 2×FAD; 2×AA; | ||||
Assess | ||||||
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 2×ZN; 2×FAD; 2×52X; | ||||
Assess | ||||||
Structure of the human quinone reductase 2 (NQO2) in complex with pacritinib | homo-2-mer | 2×FAD; 2×6T3; 4×SO4; 2×ZN; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4fgl.1.A | homo-2-mer | 0.90 | 2×ZN; 2×FAD; 2×CLQ; | 99.57 | ||
Assess |